Adenylosuccinate synthase
Adenylosuccinate Synthase is an enzyme that plays a crucial role in the purine nucleotide biosynthesis pathway. This enzyme is responsible for the synthesis of adenylosuccinate from inosine monophosphate (IMP) and aspartate, utilizing GTP as an energy source. The reaction catalyzed by adenylosuccinate synthase is an important step in the generation of adenosine monophosphate (AMP), a fundamental building block of RNA and DNA, as well as an essential component of ATP, the primary energy currency of the cell.
Function[edit | edit source]
Adenylosuccinate synthase catalyzes the first step of the two-step process that converts IMP to AMP. The enzyme binds to IMP and aspartate and facilitates the nucleophilic attack of the amine group of aspartate on the 6-carbon of IMP, forming adenylosuccinate. This reaction requires energy, which is provided by the hydrolysis of GTP to GDP and phosphate. The subsequent step, not catalyzed by adenylosuccinate synthase, involves the conversion of adenylosuccinate to AMP and fumarate, completing the synthesis pathway of AMP.
Genetic and Molecular Biology[edit | edit source]
The gene encoding adenylosuccinate synthase is highly conserved across different species, highlighting its essential role in cellular metabolism. In humans, the gene is located on chromosome 22 and is expressed in various tissues, with high expression levels in the liver and muscle tissues, where purine synthesis is particularly active.
Mutations in the gene encoding adenylosuccinate synthase can lead to a rare metabolic disorder known as Adenylosuccinate Lyase Deficiency, characterized by the accumulation of succinylpurines in the body. This condition can result in neurological symptoms, including autism, muscle weakness, and intellectual disability.
Clinical Significance[edit | edit source]
Given its central role in purine metabolism, adenylosuccinate synthase is a potential target for therapeutic intervention in diseases associated with purine dysregulation, such as gout and certain types of cancer. Inhibitors of adenylosuccinate synthase could potentially reduce the availability of AMP, thereby affecting the synthesis of nucleic acids and impacting cell proliferation.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD